Tuberculosis - World Health Organization (WHO)
Oct 29, 2024 · Tuberculosis (TB) is an infectious disease caused by bacteria that most often affects the lungs. It spreads through the air when people with TB cough, sneeze or spit. Tuberculosis is preventable and curable. About a quarter of the global population is estimated to have been infected with TB bacteria.
Tuberculosis - World Health Organization (WHO)
Nov 20, 2024 · Tuberculosis (TB) is the world’s top infectious killer. Nearly 4500 people lose their lives and 30 000 people fall ill with TB each day. TB is contagious and airborne. It is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs. TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel TB …
WHO TB guidelines: recent updates - World Health Organization …
The communication includes new information about treatment decision algorithms, the use of Xpert MTB/RIF Ultra to diagnose pulmonary TB using gastric aspirate and stool specimens, a 4-month regimen to treat non-severe, drug-susceptible pulmonary TB, the use of bedaquiline and delamanid to treat drug-resistant TB, a shortened intensified regimen ...
Tuberculosis - World Health Organization (WHO)
Jan 18, 2018 · Tuberculosis (TB) is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs. Tuberculosis is curable and preventable. TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air.
10 facts on tuberculosis - World Health Organization (WHO)
About one quarter of the world’s population is infected with tuberculosis (TB) bacteria. Only a small proportion of those infected will become sick with TB. People with weakened immune systems have a much greater risk of falling ill from TB. A person living with HIV is about 20 times more likely to develop active TB.
Tuberculosis: Systematic screening - World Health Organization …
May 23, 2024 · Tuberculosis preventive treatment (TPT) consists of a course of one or more anti-tuberculosis medicines given with the intent of preventing the development of TB disease. TPT is only given to people who are infected with TB bacteria, or who have been exposed to it, and who are at a higher risk of developing TB disease.
Tuberculosis: Multidrug-resistant (MDR-TB) or rifampicin-resistant …
The key factors that define treatment regimen choice include the patient's drug-resistance profile, prior exposure to TB medicines and patient history, the drug-resistance profile of close contacts, the patient’s age, the extent of pulmonary TB disease, and …
Global tuberculosis report 2024 - World Health Organization (WHO)
Oct 29, 2024 · The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
4. TB prevention - World Health Organization (WHO)
Globally in 2020, 7.0 million contacts of bacteriologically confirmed pulmonary TB cases were reported, of whom 3.9 million (55%) were evaluated for both TB infection and disease. These numbers were decreases (of 29% and 31%, respectively) from the 9.8 million reported and 5.6 million evaluated in 2019.
Preventing TB - World Health Organization (WHO)
Tuberculosis (TB) infection is extremely common: an estimated one-quarter of the world’s population is infected. People with TB infection risk developing TB disease and this risk depends on multiple factors, the most important being the state of their immune system.TB preventive treatment stops TB infection from progressing to disease in those who are infected and can …